RUNX1 activities in normal megakaryopoiesis and hematopoietic stem cell maintenance, and their relations to hematological diseases, have been extensively studied for many years and, therefore, will not be covered in the present review. This evidence concerns the gene RUNX1 and hematologic disorder.